HMGA1 and non-small cell lung carcinoma: In this study, a prognostic risk-scoring model for NSCLC was established based on prognostic LRGs that were significantly differentially expressed between NSCLC and control groups (VIPR1, NEK2, HMGA1, FERMT1, SLC7A5, and TNS4).